UBS Group AG - QIAGEN NV ownership

QIAGEN NV's ticker is and the CUSIP is N72482AB3. A total of 8 filers reported holding QIAGEN NV in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of QIAGEN NV
ValueSharesWeighting
Q3 2020$236,000
+37.2%
128,000
+8.5%
0.00%
Q2 2020$172,000
+72.0%
118,000
+47.5%
0.00%
Q4 2019$100,00080,0000.00%
Other shareholders
QIAGEN NV shareholders Q3 2020
NameSharesValueWeighting ↓
EXANE DERIVATIVES 4$1,466,150,0000.42%
Zurcher Kantonalbank (Zurich Cantonalbank) 1,800,000$3,239,0000.02%
AMUNDI ASSET MANAGEMENT US, INC. 1,600,000$2,954,0000.00%
BARCLAYS PLC 1,000,000$1,823,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 128,000$236,0000.00%
CREDIT SUISSE AG/ 400,000$738,0000.00%
JPMORGAN CHASE & CO 1,400,000$2,551,0000.00%
View complete list of QIAGEN NV shareholders